Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermodysplasia verruciformis 1 pseudogene (ENSG00000233708) is a non-functional DNA sequence in the human genome that shares homology with genes implicated in epidermodysplasia verruciformis 1. Unlike the parent genes TMC6 and TMC8, which encode proteins involved in disease susceptibility, this pseudogene cannot produce a functional protein and does not contribute to biological processes or serve as a therapeutic target. Pseudogenes are primarily distinguished by their inability to generate functional products, though they can complicate genomic analyses when mistaken for functional genes[1][3][2]. This entry does not correspond to a classical therapeutic target (receptor, enzyme, transporter, etc.), and its identification here is likely due to nomenclature overlapping with disease-related genes rather than functional relevance. The parent EV1-related genes (e.g., TMC6, TMC8) are involved in mechanosensitive ion channel function and disease susceptibility, but the ENSG00000233708 pseudogene is itself not a target for therapy, biomarker investigation, or drug development[2][1][3].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermodysplasia verruciformis 1 pseudogene (null).